- French pharmaceutical company Sanofi has made a public bid for shares in the Hungarian drug company Chinoin, in which the French firm already has a majority stake, according to a report by Reuters. Sanofi has not commented on the matter. The company will offer 61,500 forint ($4.00) for each share which has a 10,000 forint face value, Chinoin's general director Miklos Gyorgy told shareholders at the firm's annual general meeting. Acceptance will run from June 3 to July 5.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze